banner
TGF-β-Smad inhibitor SB 431542, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ805

TGF-β-Smad inhibitor SB 431542, Purity ≥98%

Synonym: 301836-41-9; SB-431542; SB 431542; 4-(4-(Benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide; SB431542; 4-[4-(1,3-BENZODIOXOL-5-YL)-5-(2-PYRIDINYL)-1H-IMIDAZOL-2-YL]BENZAMIDE; TGF-β-Smad inhibitor

  • MDL: MFCD05865244
  • CAS Number: 301836-41-9
  • Compound CID: 4521392
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
SB 431542, soluble in DMSO and ethanol and insoluble in water, is a potent and specific inhibitor of TGF-β-Smad signaling pathway activation. It targets ALK4, ALK5, and ALK7.
Molecular Weight
384.4
Molecular Formula
C22H16N4O3
Targets
ALK4; ALK5: 94 nM; ALK7
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 75 mg/mL (195.11 mM); Water: Insoluble; Ethanol: 3 mg/mL (7.8 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
SB 431542 can be used to study its inhibition of TGF-β1 receptor kinase and its effects on cellular processes such as proliferation and differentiation.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0